United Therapeutics Corp.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $1.13B | $3.91B | $738.4M |
| FY2020 | $1.22B | $4.62B | $738.7M |
| FY2021 | $1.21B | $5.17B | $894.8M |
| FY2022 | $1.25B | $6.04B | $961.2M |
| FY2023 | $1.18B | $7.17B | $1.21B |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $1.13B | $3.91B | $738.4M |
| FY2020 | $1.22B | $4.62B | $738.7M |
| FY2021 | $1.21B | $5.17B | $894.8M |
| FY2022 | $1.25B | $6.04B | $961.2M |
| FY2023 | $1.18B | $7.17B | $1.21B |